Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Abriola, L.
Right arrow Articles by Sills, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abriola, L.
Right arrow Articles by Sills, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Digital Imaging as a Detection Method for a Fluorescent Protease Assay in 96-Well and Miniaturized Assay Plate Formats

Laura Abriola

Novartis Institute of Biomedical Research, Summit, NJ

Michael Chin

Novartis Institute of Biomedical Research, Summit, NJ

Peter Fuerst

Novartis Pharma AG, Basel, Switzerland

Robert Schweitzer

Novartis Institute of Biomedical Research, Summit, NJ

Matthew A. Sills

Novartis Institute of Biomedical Research, Summit, NJ

The demand to increase throughput in HTS programs, without a concomitant addition to costs, has grown significantly during the past few years. One approach to handle this demand is assay miniaturization, which can provide greater throughput, as well as significant cost savings through reduced reagent costs. Currently, one of the major challenges facing assay miniaturization is the ability to detect the assay signal accurately and rapidly in miniaturized formats. Digital imaging is a detection method that can measure fluorescent or luminescent signals in these miniaturized formats. In this study, an imaging system capable of detecting the signal from a fluorescent protease assay in multiple plate formats was used to evaluate this detection method in an HTS environment. A direct comparison was made between the results obtained from the imaging system and a fluorescent plate reader by screening 8,800 compounds in a 96-well plate format. The imaging system generated similar changes in relative signal for each well in the screen, identified the same active compounds, and yielded similar IC50 values as compared to the plate reader. When a standard protease inhibitor was evaluated in 96-, 384-, 864-, and 1536-well plates using imaging detection, similar IC50 values were obtained. Furthermore, similar dose-response curves were generated for the compound in 96- and 384-well assay plates read in a plate reader. These results provide support for digital imaging as an accurate and rapid detection method for high-density microtiter plates.

Journal of Biomolecular Screening, Vol. 4, No. 3, 121-127 (1999)
DOI: 10.1177/108705719900400305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
I. Kariv, H. Cao, P. D. Marvil, E. V. Bobkova, Y. E. Bukhtiyarov, Y. P. Yan, U. Patel, L. Coudurier, T. D.Y. Chung, and K. R. Oldenburg
Identification of Inhibitors of Bacterial Transcription/Translation Machinery Utilizing a Miniaturized 1536-Well Format Screen
J Biomol Screen, August 1, 2001; 6(4): 233 - 243.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
G. Ferry and J. A. Boutin
High-Capacity Screening of Arylalkylamine N-Acetyltransferase Inhibitors using a High-Performance Liquid Chromatography System
J Biomol Screen, October 1, 2000; 5(5): 361 - 368.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
D. Dunn, M. Orlowski, P. McCoy, F. Gastgeb, K. Appell, L. Ozgur, M. Webb, and J. Burbaum
Ultra-High Throughput Screen of Two-Million-Member Combinatorial Compound Collection in a Miniaturized, 1536-Well Assay Format
J Biomol Screen, June 1, 2000; 5(3): 177 - 187.
[Abstract] [PDF]